Co-occurrence of TERT promotor mutations with BRAF or NRAS alterations correlates with worse prognosis in melanoma. Sheen YS, Chu CY. Br J Dermatol 2020 Jul 22. doi: 10.1111/bjd.19416.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sheen YS, Chu CY. Co-occurrence of TERT promotor mutations with BRAF or NRAS alterations correlates with worse prognosis in melanoma. Br J Dermatol 2020 Jul 22. doi: 10.1111/bjd.19416.
PMID: 33448329